GlassScriptPhysician profile
John S Regan
NPI 1588672802
$7,472.03
in general payments reported to CMS, 2019-2025
47 companies · $1,316 in 2025
The $1,316 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $819 · 2020: $402 · 2021: $877 · 2022: $1,125 · 2023: $1,266 · 2024: $1,668 · 2025: $1,316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,181 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,181.44 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,714.04 | 2019-2025 | Erleada |
| Astellas Pharma US INC | $828.51 | 2019-2024 | Myrbetriq, Xtandi, Veozah |
| Pfizer INC. | $505.82 | 2019-2025 | |
| Abbvie INC. | $421.19 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $387.57 | 2023-2025 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $330.68 | 2019-2023 | Edex, Xiaflex, Aveed |
| Ferring Pharmaceuticals INC. | $316.26 | 2024-2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $277.99 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $229.42 | 2020-2024 | Keytruda, Lynparza |
| Rochester Medical Corporation | $172.96 | 2020-2022 | |
| Myriad Genetic Laboratories, INC. | $171.66 | 2022-2025 | Prolaris, Myrisk |
| Endo USA, INC. | $170.67 | 2024-2025 | Xiaflex, Aveed, Edex |
| Neotract INC. | $166.49 | 2019-2020 | |
| Coloplast Corp | $166.30 | 2021-2025 | Speedicath, Luja Coude |
| Boston Scientific Corporation | $157.81 | 2019-2024 | Spaceoar Vue System - 10ml, Lithovue |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $129.46 | 2024 | Bard Urinary Drainage Bag |
| Olympus America INC. | $120.58 | 2023-2025 | Itind System, Soltive |
| Teleflex LLC | $107.13 | 2022-2025 | Urolift |
| 180 Medical, INC. | $104.95 | 2019-2025 | Gentlecath |
| Tolmar Pharmaceuticals, INC. | $88.41 | 2019-2021 | |
| Tolmar, INC. | $79.08 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $76.68 | 2020-2024 | Lynparza |
| Blue Earth Diagnostics | $63.92 | 2019-2022 | |
| Urovant Sciences INC | $61.30 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $59.10 | 2022-2024 | Pylarify |
| Hollister Incorporated | $46.33 | 2020-2023 | Vapro Plus Pocket |
| C. R. Bard, INC. & Subsidiaries | $46.06 | 2020 | |
| Procept Biorobotics Corporation | $43.09 | 2022-2024 | Aquabeam System |
| Convatec INC. | $38.06 | 2021 | |
| Dendreon Pharmaceuticals LLC | $32.60 | 2024 | Provenge |
| Urogen Pharma, INC. | $31.92 | 2023 | Jelmyto |
| Dornier Medtech America, INC | $31.23 | 2019 | |
| Immunitybio, INC. | $30.73 | 2025 | |
| Organon LLC | $27.43 | 2025 | Nexplanon |
| Therapeuticsmd, INC. | $25.69 | 2019 | |
| Novartis Pharmaceuticals Corporation | $25.24 | 2025 | |
| Calyxo, INC. | $24.33 | 2025 | Cvac Aspiration System |
| Palette Life Sciences, INC. | $19.51 | 2022 | |
| Photocure INC | $19.08 | 2019 | |
| Abc Home Medical Supply, INC. | $18.86 | 2025 | |
| Koelis INC. | $18.46 | 2024 | |
| Accord Healthcare, INC. | $17.38 | 2025 | |
| Smith+Nephew, INC. | $16.66 | 2019 | |
| Axonics, INC. | $14.46 | 2024 | Axonics |
| Karl Storz Endoscopy-America | $13.53 | 2021 | |
| Cook Medical LLC | $12.31 | 2019 | |
| Allergan, INC. | $11.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Regan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.